Another pandemic of COVID-19? The entire country is on high alert as the deadly COVID-19 virus is resurfacing in india after a brief hiatus. The studies say that NB.1.8.1, a novel and rapidly spreading COVID-19 variant, has been identified nationwide and is thought to be the cause of the recent spike in infections in 20 states. Although symptoms may initially seem moderate, health experts caution that the variation is extremely deadly due to its high transmissibility and covert spread.
All You Need To Know About The NB.1.8.1 Dscendant of JN.1 COVID Variant
Officials have disclosed that NB.1.8.1, a new and more deadly strain of the COVID-19 virus, is rapidly spreading throughout the nation as of May 2025. NB.1.8.1, a subvariant of the Omicron lineage JN.1, has been identified in the united states and has been associated with recent spikes in cases throughout Asia. health officials are keeping a careful eye on its spread, but it's important to know what this variety is and how it could impact us.
What is this new variation of COVID-19? The extremely contagious JN.1 variety, which is now prominent in Asia, is the ancestor of the recently discovered NB.1.8.1 COVID mutation, according to experts. Conversely, JN.1 is a sublineage of Omicron itself. Since its initial discovery in China, NB.1.8.1 has quickly taken over as the predominant strain, resulting in a notable rise of COVID-19 cases. Through airport screening measures, its existence has also been verified in other Asian countries, such as singapore and Hong Kong, and more recently, in the US.
What do you need to know about this variant?
China was the first to identify this recently discovered variation in India. According to specialists, the initial outbreak of NB.1.8.1 caused a great deal of damage throughout China. This variation quickly took over as the predominant strain there, which resulted in a sharp rise in COVID-19 cases. Through airport screening measures, its existence has also been verified in other Asian countries, such as singapore and Hong Kong, and more recently, in the US.
The World health Organization (WHO) and indian health authorities are currently keeping a close eye on NB.1.8.1, a sub-lineage of the Omicron JN.1 strain that was first discovered in tamil Nadu in april 2025, according to health officials. The national COVID landscape has become even more complicated with the discovery of another subvariant, LF.7, in Gujarat.
What is WHO saying?
The World health Organization (WHO) stated that "NB.1.8.1 has been designated a SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally," in recognition of the current circumstances in india and other regions where COVID is resurfacing.
The earliest sample of NB.1.8.1, a SARS-CoV-2 variation that is produced from the recombinant variant XDV.1.5.1, was taken on january 22, 2025. The WHO tracks six VUMs, including NB.1.8.1, which was classified as a VUM on May 23, 2025," the statement continued.
All You Need To Know About The NB.1.8.1 Dscendant of JN.1 COVID Variant
Officials have disclosed that NB.1.8.1, a new and more deadly strain of the COVID-19 virus, is rapidly spreading throughout the nation as of May 2025. NB.1.8.1, a subvariant of the Omicron lineage JN.1, has been identified in the united states and has been associated with recent spikes in cases throughout Asia. health officials are keeping a careful eye on its spread, but it's important to know what this variety is and how it could impact us.
What is this new variation of COVID-19? The extremely contagious JN.1 variety, which is now prominent in Asia, is the ancestor of the recently discovered NB.1.8.1 COVID mutation, according to experts. Conversely, JN.1 is a sublineage of Omicron itself. Since its initial discovery in China, NB.1.8.1 has quickly taken over as the predominant strain, resulting in a notable rise of COVID-19 cases. Through airport screening measures, its existence has also been verified in other Asian countries, such as singapore and Hong Kong, and more recently, in the US.
What do you need to know about this variant?
China was the first to identify this recently discovered variation in India. According to specialists, the initial outbreak of NB.1.8.1 caused a great deal of damage throughout China. This variation quickly took over as the predominant strain there, which resulted in a sharp rise in COVID-19 cases. Through airport screening measures, its existence has also been verified in other Asian countries, such as singapore and Hong Kong, and more recently, in the US.
The World health Organization (WHO) and indian health authorities are currently keeping a close eye on NB.1.8.1, a sub-lineage of the Omicron JN.1 strain that was first discovered in tamil Nadu in april 2025, according to health officials. The national COVID landscape has become even more complicated with the discovery of another subvariant, LF.7, in Gujarat.
What is WHO saying?
The World health Organization (WHO) stated that "NB.1.8.1 has been designated a SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally," in recognition of the current circumstances in india and other regions where COVID is resurfacing.
The earliest sample of NB.1.8.1, a SARS-CoV-2 variation that is produced from the recombinant variant XDV.1.5.1, was taken on january 22, 2025. The WHO tracks six VUMs, including NB.1.8.1, which was classified as a VUM on May 23, 2025," the statement continued.
click and follow Indiaherald WhatsApp channel